OTC: BRRN

Bryn Inc.

CIK 0001397795 · SIC 8741 · Management Services

Micro Revenue $41K Assets $2K as of Aug 16, 2026

Byrn, Inc. f/k/a “Quture International, Inc. (“Byrn”, “we”, “us”, or, the “Company”), is a Nevada corporation that was formed in April 2011 to become an emerging healthcare knowledge solution company created to transform health and healthcare by developing the standard in measuring clinical… About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.

10-Q Filed Aug 14, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

10-Q Filed May 19, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

Partner

Trade BRRN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed May 11, 2026 · Period ending Apr 24, 2026

Summary not yet generated.

10-K Filed Apr 2, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Oct 21, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Jul 24, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Apr 15, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

8-K Filed Feb 16, 2021 · Period ending Feb 16, 2021

Summary not yet generated.

8-K Filed Feb 10, 2021 · Period ending Feb 10, 2021

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Statements of Operations (Unaudited)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Revenue - - - -
Operating Expenses:
Administrative expenses 178,646 8,472 209,583 24,882
Total operating expenses 178,646 8,472 209,583 24,882
(Loss) from operations (178,646) (8,472) (209,583) (24,882)
Other (expense) net - - - -
Income (loss) before provision for income taxes (178,646) (8,472) (209,583) (24,882)
Provision for income taxes - - - -
Net Loss (178,646) (8,472) (209,583) (24,882)
Basic and diluted (loss) per common share (0.00) (0.00) (0.00) (0.00)
Weighted average number of shares outstanding 450,000,000 419,763,612 450,000,000 419,984,423

Balance Sheets

Description June 30, 2026 (Unaudited) December 31, 2025
ASSETS
Prepaid expenses 804 -
Accounts receivable other 1,105 -
Current assets 1,909 -
Total Assets 1,909 -
LIABILITIES & STOCKHOLDERS’ DEFICIT
Accounts payable 67,133 7,577
Related party loans 139,037 89,035
Current liabilities 206,170 96,612
Total liabilities 206,170 96,612
Stockholders’ Deficit
Preferred stock, par value $0.001, 10,000,000 shares authorized, 10,000,000 issued and outstanding as of June 30, 2026 and December 31, 2025 respectively 10,000 10,000
Common stock, par value $0.001, 500,000,000 shares authorized, 450,000,000 and 419,984,423 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 450,000 419,985
Additional paid in capital 117,107,459 117,035,540
Accumulated deficit (117,771,719) (117,562,137)
Total Stockholders’ (Deficit) (204,260) (96,612)
Total Liabilities and Stockholders’ Deficit 1,909 -

Statements of Cash Flows (Unaudited)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash Flows From Operating Activities:
Net (loss) (209,583) (24,882)
Changes in operating assets and liabilities:
Prepaid expenses (804) -
Accounts receivable other (1,105) -
Accounts payable and accrued expenses 59,556 (10,819)
Net cash (used in) operating activities (151,936) (35,700)
Cash Flows From Investing Activities:
Net cash provided by (used in) investing activities - -
Cash Flows From Financing Activities:
Proceeds from related party loans 151,936 35,700
Net cash provided by financing activities 151,936 35,700
Net Increase (Decrease) In Cash - -
Cash At The Beginning Of The Period - -
Cash At The End Of The Period - -
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued to reduce related party debt 93,285 -

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About Bryn Inc.

Source: Item 1 (Business) from the 10-K filed April 2, 2026. Description as filed by the company with the SEC.

ITEM 1. BUSINESS

Overview

Corporate History

Byrn, Inc. f/k/a “Quture International, Inc. (“Byrn”,
“we”, “us”, or, the “Company”), is a Nevada corporation that was formed in April 2011 to become an
emerging healthcare knowledge solution company created to transform health and healthcare by developing the standard in measuring clinical
performance and outcomes. The Company developed medical software with tools and analytics intended to reduce costs while improving clinical
performance, outcomes, predictive insight, and evidence-based best clinical processes.

On August 10, 2011, holders of a majority of the
Registrant’s outstanding Common Stock voted to amend the Registrant’s Articles of Incorporation to increase the number of
its authorized shares of capital stock from 900,000,000 shares to 2,510,000,000 par value $0.001 shares (the “Amendment”)
of which (a) 2,500,000,000 shares were designated as Common Stock and (b) 10,000,000 shares were designated as blank check preferred stock.

During the period from March 22, 2013, through
December 26, 2019, the Company was dormant.

On December 27, 2019, Custodian Ventures, LLC,
an entity controlled by David Lazar, was appointed by the Nevada Court as the custodian of Byrn, Inc. f/k/a Quture International. On December
31, 2019, Mr. Lazar became the only Director and Officer of the Company also acting as its President, Treasurer, and Secretary.

On April 5, 2020, the Company granted Mr. Lazar
10,000,000 preferred shares with super-voting rights of 21,000,000,000 common shares. Each preferred share is convertible into 250 shares
of common stock.

Read full description ↓

On September 10, 2020, the Company filed a Certificate
of Designation with the State of Nevada changing the conversion and voting rights of the Company’s Series A preferred stock, $.001
par value per share to 250 for each one (1) share of Series A preferred stock.

On September 23, 2020, as a result of a private
transaction, 10,000,000 shares of Series A Convertible Preferred Stock, $0.001 par value per share (the “Shares”) of the Company
were transferred from Custodian Ventures, LLC (the “Seller”) to FiveT Capital Holding AG (the “Purchaser”). As
a result, the Purchaser became an approximately 50.2% holder of the voting rights of the issued and outstanding share capital of the Company
on a fully-diluted basis of the Company and became the controlling shareholder. In connection with the transaction, David Lazar released
the Company from all debts owed to him and/or the Seller.

On September 23, 2020, the existing director and
officer resigned immediately. Accordingly, David Lazar, serving as a director and an officer, ceased to be the Company’s Chief Executive
Officer, Chief Financial Officer, President, Treasurer, Secretary, and Director.

Also on November 24, 2020, the Company amended
its articles of incorporation to reverse split its common stock at a rate of 1 for 1,000 (the “Reverse”). Additionally, the
number of common shares authorized was reduced from 2,500,000,000 to 500,000,000. On December 1, 2020, FINRA declared the Name Change
and the Reverse effective.

On November 24, 2020, the Company amended its
articles of incorporation to change its name from Quture International, Inc. to Born, Inc. (the “Name Change”). The change
was made in anticipation of entering into a new line of business operations.

1

On February 2, 2021, the Company changed its fiscal year-end to December
31.

On February 16, 2021, Byrn, Inc. (the “Company”)
entered into a share exchange agreement (the “Share Exchange Agreement”) with Alkeon Creators, Inc. (“Alkeon”),
a United Kingdom corporation. Under the Share Exchange Agreement, One Hundred Percent (100%) of the ownership interest of Alkeon was exchanged
for 406,646,919 shares of common stock of the Company. The former stockholders of Alkeon acquired a majority of the issued and outstanding
common stock as a result of the share exchange transaction. The transaction has been accounted for as a recapitalization of the
Company, whereby Alkeon is the accounting acquirer.

Immediately after completion of such share exchange
on February 16, 2021, the Company had a total of 409,353,807 issued and outstanding shares, with authorized share capital for common share
of 500,000,000.

The transaction with Alkeon was voided and written off in February
2021. As a result, the Company was considered a dormant shell from February 2021 through July 2023 when it went again into custodianship
with Custodian Ventures.

On July 16, 2024 the Company changed its name
to Byrn Inc.

Business Overview

Byrn was a holding company that specialized in
digital, data-led solutions to digitize retail supply chains and reimagine discovery and transactions online.

Competition

Byrn, Inc. is currently a dormant shell company.